A Double Blind Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debridement of VLU (VALUE)

Recruiting

Phase 3

EscharExA Double Blind Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debridement of VLU (VALUE)

Sponsor:

MediWound Ltd

Code:

NCT06568627

Conditions

Venous Leg Ulcer (VLU)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

EscharEx (EX-03)

Placebo (Gel vehicle)

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-01-25. This information was provided to ClinicalTrials.gov by MediWound Ltd on 2025-04-24.